Success Metrics

Clinical Success Rate

87.5%

Based on 14 completed trials

Completion Rate

88%(14/16)

Active Trials

0(0%)

Results Posted

71%(10 trials)

Terminated

2(12%)

Phase Distribution

Ph not_applicable

12%

Ph phase_2

35%

Ph phase_3

24%

Ph phase_4

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution17 total trials

Phase 2Efficacy & side effects

6(35.3%)

Phase 3Large-scale testing

4(23.5%)

Phase 4Post-market surveillance

5(29.4%)

N/ANon-phased studies

2(11.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

14 of 16 finished

Non-Completion Rate

12.5%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(14)

Terminated(2)

Other(1)

Detailed Status

Completed14

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

87.5%

Most Advanced

Phase 4

Trials by Phase

Phase 26 (35.3%)

Phase 34 (23.5%)

Phase 45 (29.4%)

N/A2 (11.8%)

Trials by Status

completed1482%

terminated212%

unknown16%

Recent Activity

0 active trials

Showing 5 of 17

completedphase_4

Effect of Vitamin B on Plasma Neurofilament Light Protein (NFL) in HIV-infected Individuals With Increased Plasma Homocysteine

NCT02773147

completedphase_3

A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis

NCT00299104

View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials

NCT05288153Phase 4

Metformin Efficacy and Safety for Gastric Intestinal Metaplasia

Completed

NCT00272324Phase 2

Aspirin/Folate Prevention of Large Bowel Polyps

Completed

NCT00249288Phase 4

Folate Supplementation in Schizophrenia

Completed

NCT02773147Phase 2

Effect of Vitamin B on Plasma Neurofilament Light Protein (NFL) in HIV-infected Individuals With Increased Plasma Homocysteine

Unknown

NCT00299104Phase 3

A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis

Completed

NCT00299130Phase 3

A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis

Completed

NCT00227019Phase 2

Phase 2 Trial of Bevacizumab in Combination With Pemetrexed

Completed

NCT00572741Not Applicable

Treating Oxidative Stress and the Metabolic Pathology of Autism

Completed

NCT00298272Phase 2

Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

Terminated

NCT01356966Phase 2

Exercise Intolerance in Renal Failure

Completed

NCT00462345Phase 4

A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.

Completed

NCT01180933Not Applicable

Fish Oil and Folate Supplementation During Pregnancy

Completed

NCT01283971Phase 4

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Terminated

NCT00266227Phase 3

A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate

Completed

NCT00243412Phase 2

A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate

Completed

NCT00056225Phase 3

VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)

Completed

NCT00164970Phase 4

Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?